Inhibitor of NF-kappa B kinases alpha and beta are both essential for high mobility group box 1-mediated chemotaxis [corrected].
Inhibitor of NF-kappaB kinases beta (IKKbeta) and alpha (IKKalpha) activate distinct NF-kappaB signaling modules. The IKKbeta/canonical NF-kappaB pathway rapidly responds to stress-like conditions, whereas the IKKalpha/noncanonical pathway controls adaptive immunity. Moreover, IKKalpha can attenuate IKKbeta-initiated inflammatory responses. High mobility group box 1 (HMGB1), a chromatin protein, is an extracellular signal of tissue damage-attracting cells in inflammation, tissue regeneration, and scar formation. We show that IKKalpha and IKKbeta are each critically important for HMGB1-elicited chemotaxis of fibroblasts, macrophages, and neutrophils in vitro and neutrophils in vivo. By time-lapse microscopy we dissected different parameters of the HMGB1 migration response and found that IKKalpha and IKKbeta are each essential to polarize cells toward HMGB1 and that each kinase also differentially affects cellular velocity in a time-dependent manner. In addition, HMGB1 modestly induces noncanonical IKKalpha-dependent p52 nuclear translocation and p52/RelB target gene expression. Akin to IKKalpha and IKKbeta, p52 and RelB are also required for HMGB1 chemotaxis, and p52 is essential for cellular orientation toward an HMGB1 gradient. RAGE, a ubiquitously expressed HMGB1 receptor, is required for HMGB1 chemotaxis. Moreover, IKKbeta, but not IKKalpha, is required for HMGB1 to induce RAGE mRNA, suggesting that RAGE is at least one IKKbeta target involved in HMGB1 migration responses, and in accord with these results enforced RAGE expression rescues the HMGB1 migration defect of IKKbeta, but not IKKalpha, null cells. Thus, proinflammatory HMGB1 chemotactic responses mechanistically require the differential collaboration of both IKK-dependent NF-kappaB signaling pathways.
Penzo
Marianna
M
Vita-Salute San Raffaele University, School of Medicine, San Raffaele Scientific Institute, Milano, Italy.
Molteni
Raffaella
R
Suda
Tomomi
T
Samaniego
Sylvia
S
Raucci
Angela
A
Habiel
David M
DM
Miller
Frederick
F
Jiang
Hui-Ping
HP
Li
Jun
J
Pardi
Ruggero
R
Palumbo
Roberta
R
Olivotto
Eleonora
E
Kew
Richard R
RR
Bianchi
Marco E
ME
Marcu
Kenneth B
KB
D000818:Animals; D002478:Cells, Cultured; D002633:Chemotaxis / Q000235:genetics / Q000276:immunology*; D005347:Fibroblasts / Q000166:cytology / Q000201:enzymology / Q000276:immunology; D024243:HMGB1 Protein / Q000502:physiology*; D051550:I-kappa B Kinase / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D008264:Macrophages / Q000166:cytology / Q000201:enzymology / Q000276:immunology; D051379:Mice; D018345:Mice, Knockout; D008822:Mice, Transgenic; D009504:Neutrophils / Q000166:cytology / Q000201:enzymology / Q000276:immunology; D011994:Recombinant Proteins / Q000494:pharmacology; D015398:Signal Transduction / Q000235:genetics / Q000276:immunology
D024243:HMGB1 Protein; D011994:Recombinant Proteins; C496564:Chuk protein, mouse; D051550:I-kappa B Kinase; C496562:Ikbkb protein, mouse